Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
NAV4694 (formerly AZD4694)
print preview
bookmark
share with colleague
General Information
Company
AstraZeneca plc
Description
Fluorine-18 (F-18) labeled PET imaging agent that binds beta amyloid
Molecular Target
Mechanism of Action
Diagnostic; Imaging agent
Latest Stage of Development
Phase II
Indication
Neurology, Diagnostic
Partner
Navidea Biopharmaceuticals Inc.
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy
General Information